Functional Assessment of Cancer Therapy in Ovarian Cancer: Comprehensive Biomarker Panel
This test evaluates how well your ovarian cancer treatment is working by measuring key biomarkers in your blood. It helps doctors monitor changes in your body’s response to therapy over time.
This test helps track treatment effectiveness and adjust care as needed.
Key facts at a glance
- LOINC
- 70521-0
- Short code
- FUNCTIONALASSESSMENTOFCANCERTHERAPYFORPATIENTSWITHOVARIANCANCERQUESTIO
- Synonyms
- —
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Critical range
- 0.5 N/A – —
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- facit
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What This Test Measures
Your blood sample will be analyzed for a variety of biomarkers that reflect different aspects of your cancer and treatment response. These may include markers related to tumor activity, immune response, and metabolic changes. The exact tests performed depend on your specific treatment plan and may include measures of growth factors, inflammation indicators, and other proteins that respond to therapy.
Why It Matters for Your Treatment
Ovarian cancer treatments can affect how your body produces certain proteins and cells. This test helps doctors determine whether your treatment is working by checking for changes in these biomarkers. Early detection of shifts can guide decisions about continuing, adjusting, or stopping treatment.
Sample Collection and Preparation
A blood sample will be drawn from a vein in your arm. The blood is processed to separate components for testing. This process is quick and typically done in a clinical setting. Your doctor will explain the procedure and answer any questions before the test.
How Results Are Used
Results are reviewed by your healthcare team to compare against baseline measurements or expected changes due to treatment. They help tailor your care, such as adjusting doses, switching treatments, or monitoring for side effects. Your doctor will discuss the findings with you in detail.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This panel provides a holistic view of how your body is responding to cancer therapy. Biomarkers may indicate whether tumors are shrinking, immune activity is increasing, or metabolic changes are occurring. Early identification of treatment resistance or toxicity allows for proactive adjustments to improve outcomes and quality of life.
Short name
Therapy Response Biomarker Panel
Frequently asked questions
How often will I need this test?
What if my results show changes in biomarkers?
Do I need to prepare for this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy